John E. Davis sells AORT shares; Form 144 shows vesting and trades (AORT)

Rhea-AI Filing Summary

John E. Davis reported insider share transactions under Form 144 relating to AORT common stock. The filing lists proposed restricted-stock vesting of 4,573 shares on 02/27/2026 and discloses sales executed in the prior three months: 3,773 shares on 02/23/2026 ($141,817.64), 2,075 shares on 02/24/2026 ($74,062.77), and 2,784 shares on 03/02/2026 ($105,861.32).

Insights

Compliance Counsel

Routine Form 144 disclosure of insider sales and a restricted stock vesting.

The filing lists specific sale transactions by John E. Davis, showing exact share counts and gross proceeds for each trade dated 02/23/2026, 02/24/2026, and 03/02/2026. It also lists a restricted stock vesting of 4,573 shares on 02/27/2026.

These entries are procedural disclosures required for proposed sales; cash‑flow treatment to the issuer or holder is not stated in the excerpt. Subsequent filings or broker records would show final sale settlement details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4573	172747.82	47883897	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/27/2026	Restricted Stock Vesting	Issuer			4573	02/27/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John E. Davis 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	02/23/2026	3773	141817.64
John E. Davis 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	02/24/2026	2075	74062.77
John E. Davis 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	03/02/2026	2784	105861.32

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the AORT Form 144 filed by John E. Davis disclose?

The Form 144 discloses sales of common stock and a restricted stock vesting. It lists 3,773, 2,075, and 2,784 share sales on 02/23/2026, 02/24/2026, and 03/02/2026, plus a vesting of 4,573 shares on 02/27/2026.

How much gross proceeds were reported for the AORT insider sales?

The filing shows gross proceeds alongside each sale: $141,817.64 for 3,773 shares, $74,062.77 for 2,075 shares, and $105,861.32 for 2,784 shares as disclosed in the excerpt.

Does the Form 144 show when restricted AORT shares vested?

Yes. The excerpt lists a restricted stock vesting of 4,573 shares with an effective date of 02/27/2026, disclosed under the securities-to-be-sold/vesting section of the filing.

Does this Form 144 indicate whether the issuer received proceeds?

The excerpt does not state the issuer's receipt of proceeds. The filing lists insider sales and a vesting event but does not attribute cash flows to the issuer or selling holders in the provided text.